{"id":"W2021908659","doi":"10.1007/s10637-005-2903-3","title":"An NCIC-CTG phase I dose escalation pharmacokinetic study of the matrix metalloproteinase inhibitor BAY 12-9566 in combination with doxorubicin","year":2005,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"Bayer (Canada); Ontario Institute for Cancer Research; Ottawa Regional Cancer Foundation; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Pharmacokinetics; Medicine; Doxorubicin; Tolerability; Dosing; Pharmacology; Toxicity; Chemotherapy; Stomatitis; Internal medicine; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001194774,0.001682049,0.002415033,0.0008272369,0.0005266442,0.001064946,0.001323553,0.001169018,0.00286181],"category_scores_gemma":[0.00119542,0.0008791722,0.0009795938,0.000938428,0.001228256,0.001003507,0.0004212387,0.005231677,0.000856249],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001801863,"about_ca_system_score_gemma":0.002337206,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00408387,"about_ca_topic_score_gemma":0.009543863,"domain_scores_codex":[0.9995019,0.000205674,0.0000157339,0.00007685212,0.00006198943,0.0001378768],"domain_scores_gemma":[0.9992145,0.0001157445,0.0001351911,0.00008342286,0.00003203466,0.0004190011],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.417905,0.154494,0.007343317,0.0006251097,0.001468565,0.0007162853,0.000782079,0.01536817,0.2119393,0.001371107,0.01214004,0.175847],"study_design_scores_gemma":[0.3116584,0.6342669,0.02016163,0.00004695121,0.0005645335,0.0009781194,0.0001360229,0.006437507,0.01842004,0.0004154855,0.006810571,0.0001038454],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929435,0.001537384,0.000965388,0.0005676582,0.0001313729,0.001035996,0.0008361768,0.0001851653,0.00179725],"genre_scores_gemma":[0.9900926,0.001710566,0.002149981,0.000421744,0.00009608997,0.0008725848,0.001537253,0.00007851929,0.003040766],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00408387,"threshold_uncertainty_score":0.0130735,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01123225656717963,"score_gpt":0.279754509583063,"score_spread":0.2685222530158833,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}